YEHUD, Israel--(BUSINESS WIRE)--BioControl Medical (http://www.biocontrol-medical.com/), developer of advanced implantable devices for the treatment of autonomic disorders, announced today that it is enrolling patients for an international, multi-center, open-label clinical study of the CardioFit system for the treatment of Congestive Heart Failure at IRB approved sites in Europe, Israel and Australia.
